Results 221 to 230 of about 1,242,031 (332)
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness
Kizzmekia S. Corbett+58 more
openalex +1 more source
Amantadine (AMA) regulates neurocyte apoptosis and inhibits neurocyte inflammation to prevent maternal immune activation (MIA) from affecting offspring behavior. Abstract Background Maternal viral infection during pregnancy can lead to maternal immune activation (MIA), increasing the risk of neurodevelopmental disorders in offspring.
Jianfei Wu+8 more
wiley +1 more source
Anosmia and dysgeusia in patients with mild SARS-CoV-2 infection
Ruth Levinson+8 more
openalex +1 more source
Overview of the use of silica nanoparticles in vaccines against pathogens. Different kinds of vaccines against infectious diseases are currently using solid or mesoporous silica nanoparticles in their formulation. Silica microparticles and nanoparticles (SiNPs) have been studied as vehicles for vaccines.
Noe Juvenal Mendoza‐Ramírez+3 more
wiley +1 more source
Genomic epidemiology of SARS-CoV-2 in Bolivia, 2020-2024. [PDF]
Pérez-Cascales E+9 more
europepmc +1 more source
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo+14 more
semanticscholar +1 more source
The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia
Martin Pavelka+9 more
openalex +1 more source
Heterogeneous Evolution Among SARS-CoV-2 Genes and Variants of Concern. [PDF]
González-Vázquez LD+3 more
europepmc +1 more source
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Pengfei Wang+19 more
semanticscholar +1 more source